vs
PRECISION BIOSCIENCES INC（DTIL）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
READING INTERNATIONAL INC的季度营收约是PRECISION BIOSCIENCES INC的1.5倍（$50.3M vs $34.2M），PRECISION BIOSCIENCES INC净利率更高（58.9% vs -5.1%，领先64.0%），PRECISION BIOSCIENCES INC同比增速更快（5261.1% vs -14.2%），READING INTERNATIONAL INC自由现金流更多（$4.1M vs $-11.3M），过去两年PRECISION BIOSCIENCES INC的营收复合增速更高（39.5% vs 5.6%）
精准生物科学公司是一家上市的美国临床阶段基因编辑企业，总部位于北卡罗来纳州达勒姆，成立于2006年。该公司依托自主研发的ARCUS基因组编辑平台，专注于开发体内和体外两类基因编辑疗法。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
DTIL vs RDI — 直观对比
营收规模更大
RDI
是对方的1.5倍
$34.2M
营收增速更快
DTIL
高出5275.3%
-14.2%
净利率更高
DTIL
高出64.0%
-5.1%
自由现金流更多
RDI
多$15.4M
$-11.3M
两年增速更快
DTIL
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $34.2M | $50.3M |
| 净利润 | $20.1M | $-2.6M |
| 毛利率 | — | — |
| 营业利润率 | 36.6% | -1.9% |
| 净利率 | 58.9% | -5.1% |
| 营收同比 | 5261.1% | -14.2% |
| 净利润同比 | 213.5% | -14.5% |
| 每股收益（稀释后） | $2.62 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DTILRDI
| Q4 25 | $34.2M | $50.3M | ||
| Q3 25 | $13.0K | $52.2M | ||
| Q2 25 | $18.0K | $60.4M | ||
| Q1 25 | $29.0K | $40.2M | ||
| Q4 24 | $638.0K | $58.6M | ||
| Q3 24 | $576.0K | $60.1M | ||
| Q2 24 | $49.9M | $46.8M | ||
| Q1 24 | $17.6M | $45.1M |
净利润DTILRDI
| Q4 25 | $20.1M | $-2.6M | ||
| Q3 25 | $-21.8M | $-4.2M | ||
| Q2 25 | $-23.5M | $-2.7M | ||
| Q1 25 | $-20.6M | $-4.8M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $-16.4M | $-7.0M | ||
| Q2 24 | $32.7M | $-12.8M | ||
| Q1 24 | $8.6M | $-13.2M |
营业利润率DTILRDI
| Q4 25 | 36.6% | -1.9% | ||
| Q3 25 | -158976.9% | -0.6% | ||
| Q2 25 | -121538.9% | 4.8% | ||
| Q1 25 | -76248.3% | -17.2% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | -3693.6% | -0.6% | ||
| Q2 24 | 48.4% | -16.4% | ||
| Q1 24 | -23.8% | -16.7% |
净利率DTILRDI
| Q4 25 | 58.9% | -5.1% | ||
| Q3 25 | -167476.9% | -8.0% | ||
| Q2 25 | -130666.7% | -4.4% | ||
| Q1 25 | -70913.8% | -11.8% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | -2851.6% | -11.7% | ||
| Q2 24 | 65.6% | -27.4% | ||
| Q1 24 | 48.8% | -29.4% |
每股收益（稀释后）DTILRDI
| Q4 25 | $2.62 | $-0.11 | ||
| Q3 25 | $-1.84 | $-0.18 | ||
| Q2 25 | $-2.13 | $-0.12 | ||
| Q1 25 | $-2.21 | $-0.21 | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | $-2.25 | $-0.31 | ||
| Q2 24 | $4.67 | $-0.57 | ||
| Q1 24 | $1.70 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $115.6M | $10.5M |
| 总债务越低越好 | — | $185.1M |
| 股东权益账面价值 | $92.2M | $-18.2M |
| 总资产 | $154.4M | $434.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DTILRDI
| Q4 25 | $115.6M | $10.5M | ||
| Q3 25 | $44.9M | $8.1M | ||
| Q2 25 | $62.2M | $9.1M | ||
| Q1 25 | $77.2M | $5.9M | ||
| Q4 24 | $86.3M | $12.4M | ||
| Q3 24 | $101.2M | $10.1M | ||
| Q2 24 | $123.6M | $9.3M | ||
| Q1 24 | $137.8M | $7.5M |
总债务DTILRDI
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DTILRDI
| Q4 25 | $92.2M | $-18.2M | ||
| Q3 25 | $16.6M | $-12.1M | ||
| Q2 25 | $34.1M | $-7.7M | ||
| Q1 25 | $49.3M | $-8.1M | ||
| Q4 24 | $56.4M | $-4.4M | ||
| Q3 24 | $64.9M | $1.6M | ||
| Q2 24 | $74.7M | $6.5M | ||
| Q1 24 | $37.2M | $18.0M |
总资产DTILRDI
| Q4 25 | $154.4M | $434.9M | ||
| Q3 25 | $93.5M | $435.2M | ||
| Q2 25 | $108.9M | $438.1M | ||
| Q1 25 | $124.4M | $441.0M | ||
| Q4 24 | $136.4M | $471.0M | ||
| Q3 24 | $153.3M | $495.7M | ||
| Q2 24 | $165.8M | $494.9M | ||
| Q1 24 | $184.7M | $494.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-11.3M | $4.3M |
| 自由现金流经营现金流 - 资本支出 | $-11.3M | $4.1M |
| 自由现金流率自由现金流/营收 | -32.9% | 8.2% |
| 资本支出强度资本支出/营收 | 0.1% | 0.3% |
| 现金转化率经营现金流/净利润 | -0.56× | — |
| 过去12个月自由现金流最近4个季度 | — | $-2.9M |
8季度趋势，按日历期对齐
经营现金流DTILRDI
| Q4 25 | $-11.3M | $4.3M | ||
| Q3 25 | $-15.3M | $295.0K | ||
| Q2 25 | $-20.3M | $1.6M | ||
| Q1 25 | $-19.1M | $-7.7M | ||
| Q4 24 | $-58.4M | $8.0M | ||
| Q3 24 | $-5.9M | $1.3M | ||
| Q2 24 | $-14.9M | $-10.4M | ||
| Q1 24 | $-19.0M | $-2.8M |
自由现金流DTILRDI
| Q4 25 | $-11.3M | $4.1M | ||
| Q3 25 | — | $-246.0K | ||
| Q2 25 | $-20.3M | $1.2M | ||
| Q1 25 | $-19.1M | $-8.0M | ||
| Q4 24 | $-58.7M | $7.0M | ||
| Q3 24 | $-6.0M | $-1.1M | ||
| Q2 24 | $-14.9M | $-10.6M | ||
| Q1 24 | $-19.1M | $-4.7M |
自由现金流率DTILRDI
| Q4 25 | -32.9% | 8.2% | ||
| Q3 25 | — | -0.5% | ||
| Q2 25 | -112627.8% | 1.9% | ||
| Q1 25 | -65917.2% | -19.8% | ||
| Q4 24 | -9199.8% | 12.0% | ||
| Q3 24 | -1033.2% | -1.8% | ||
| Q2 24 | -29.9% | -22.7% | ||
| Q1 24 | -108.4% | -10.4% |
资本支出强度DTILRDI
| Q4 25 | 0.1% | 0.3% | ||
| Q3 25 | 0.0% | 1.0% | ||
| Q2 25 | 11.1% | 0.6% | ||
| Q1 25 | 220.7% | 0.6% | ||
| Q4 24 | 39.2% | 1.7% | ||
| Q3 24 | 6.8% | 4.0% | ||
| Q2 24 | 0.1% | 0.5% | ||
| Q1 24 | 0.5% | 4.3% |
现金转化率DTILRDI
| Q4 25 | -0.56× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.45× | — | ||
| Q1 24 | -2.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DTIL
暂无分部数据
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
